Fundraising Fox

Tempero Bio, Inc.

Oakland, US · Founded 2020 · 2 known investors

Biotech

Founders & leadership

CK
Christian KleeNamed on SEC filing
JG
Joshua GertsmanNamed on SEC filing
PJ
Paul JohnsonNamed on SEC filing
RD
Ricardo DolmetschNamed on SEC filing
JS
Julie ShahNamed on SEC filing
JJ
Joseph JimenezNamed on SEC filing
FGFrancisco Gimenez
Francisco Gimenezin𝕏Named on SEC filingInvestment Team at 8VC

Investors · 2

8VCreported · 2 sourcesAustin · $100K – $50Mvia Francisco Gimenez · board
Aditum BioreportedOakland

Funding

SEC filings, press & company announcements

$70M disclosed across 1 round · 2025

▶$77MraisedNov 2025 · 23 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christian KleeExecutive Officer
  • Joshua GertsmanDirector
  • Paul JohnsonExecutive Officer, Director
  • Ricardo DolmetschExecutive Officer, Director
  • Julie ShahExecutive Officer
  • Joseph JimenezDirector
  • Francisco GimenezDirector
Offering amount
$77M
Amount sold
$77M
First sale
Oct 2024
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders - BioSpacebiospace.com · Mar 2025Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disordersprnewswire.com · Mar 2025Tempero Bio Announces FDA Clearance of Investigational New Drug (IND) Application for TMP-301 for the Treatment of Alcohol and Other Substance Use Disordersprnewswire.com · Jan 2023

Frequently asked questions

Who are Tempero Bio, Inc.'s investors?
Tempero Bio, Inc.'s investors include 8VC, Aditum Bio.
How much funding has Tempero Bio, Inc. raised?
Tempero Bio, Inc. has disclosed $70M raised across 1 round.
Where is Tempero Bio, Inc. headquartered?
Tempero Bio, Inc. is headquartered in Oakland, US.